Pfizer deal may trigger biggest tax hit from inversion
October 29, 2015 at 14:58 PM EDT
Pfizer Inc.’s potential acquisition of Allergan PLC could mean huge tax benefits for the New York-based drug maker, and the possible deal is already stoking concern from Congress about lost revenue for the Treasury.
